File: '\\swfile\EmailIn\20240209 135358 Attachment 2024_02_09 TRUE NR change of directors, option and rsu grants.docx'

Treatment.com Announces Change of Directors

VANCOUVER, British Columbia, February 9, 2024 - Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the "Company" or "Treatment") announces the resignation of John Fraser from the Board of Directors, effective immediately.

The Board would like to thank Mr. Fraser for his contributions to the Board and wishes him all the best in his future endeavours.

The Company has granted 50,000 stock options, exercisable at $0.55 expiring on March 1, 2029, and 110,000 restricted share units, expiring on February 8, 2027, to a consultant and officer of the Company. The stock options and restricted share units are issued pursuant to the Company's share compensation plans and are subject to vesting conditions.

FOR ADDITIONAL INFORMATION, CONTACT:

Dr. Essam Hamza, CEO

mailto:ehamza@treatment.com

(612) 788-8900

Cautionary Statements

This news release contains forward-looking statements that are based on Treatment.com's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although Treatment.com believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Treatment.com undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.